063160.KS
CKD Bio Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 12,810.00
+0.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.59x
- Price / sales
- 0.44x
- Price / cash flow
- 69.84x
Enterprise value
- Enterprise value
- KRW 217.6B
- EV / sales
- 1.38x
- EV / EBITDA
- 25.48x
- EV / EBIT
- -26.97x
- Market cap
- KRW 70.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026